Literature DB >> 17459621

Mutagenic evaluation and chemical investigation of Byrsonima intermedia A. Juss. leaf extracts.

Miriam Sannomiya1, Cássia R P Cardoso, Maria E Figueiredo, Clenilson M Rodrigues, Lourdes C dos Santos, Fabio V dos Santos, Juliana M Serpeloni, Ilce M S Cólus, Wagner Vilegas, Eliana A Varanda.   

Abstract

Byrsonima intermedia is a native species of the cerrado formation (tropical American savannah). In Brazil, this plant has been used for the treatment of fever, in ulcers, as a diuretic, as antiasthmatics and in skin infections. Members of the genus Byrsonima (Malpighiaceae) are employed not only in the folk medicine but also as food to make juice, jellies and liquor. The aim of this work was to evaluate the mutagenic effects of Byrsonima intermedia, common name 'murici'. Phytochemical analysis of methanol extract furnished (+)-catechin, (-)-epicatechin, quercetin-3-O-beta-d-galactopyranoside, methyl gallate, gallic acid, quercetin-3-O-alpha-l-arabinopyranoside, amentoflavone, quercetin, quercetin-3-O-(2''-O-galloyl)-beta-galactopyranoside and quercetin-3-O-(2''-O-galloyl)-alpha-arabinopyranoside. Methanol, hydromethanol and chloroform extracts were evaluated in mutagenic assay with Salmonella typhimurium (Ames test) and mice (Micronucleus test). The methanolic extract presented signs of mutagenic activity for the strains TA98 and TA100 in the Ames assay. Mutagenicity was not observed in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17459621     DOI: 10.1016/j.jep.2007.03.014

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  8 in total

1.  Hypoglycemic Effects of sesquiterpene lactones from Byrsonima crassifolia.

Authors:  Rosa Martha Pérez Gutiérrez; Alethia Muñiz Ramirez
Journal:  Food Sci Biotechnol       Date:  2016-08-31       Impact factor: 2.391

2.  LDH, proliferation curves and cell cycle analysis are the most suitable assays to identify and characterize new phytotherapeutic compounds.

Authors:  Ana Flávia L Specian; Juliana M Serpeloni; Katiuska Tuttis; Diego L Ribeiro; Heloísa L Cilião; Eliana A Varanda; Miriam Sannomiya; Wilner Martinez-Lopez; Wagner Vilegas; Ilce M S Cólus
Journal:  Cytotechnology       Date:  2016-06-25       Impact factor: 2.058

Review 3.  A Review on the Phytochemistry, Pharmacology, and Pharmacokinetics of Amentoflavone, a Naturally-Occurring Biflavonoid.

Authors:  Sheng Yu; Hui Yan; Li Zhang; Mingqiu Shan; Peidong Chen; Anwei Ding; Sam Fong Yau Li
Journal:  Molecules       Date:  2017-02-16       Impact factor: 4.411

4.  Effect of Byrsonima sericea DC. leaf extracts on mice gastrointestinal tract.

Authors:  Patrícia de Araújo Rodrigues; Selene Maia de Morais; Liza Araújo Aguiar; Nadja Soares Vila-Nova; Stephen Rathinaraj Benjamin
Journal:  Toxicol Rep       Date:  2019-11-09

5.  Anti-Helicobacter pylori activity and immunostimulatory effect of extracts from Byrsonima crassa Nied. (Malpighiaceae).

Authors:  Cibele Bonacorsi; Maria Stella G Raddi; Iracilda Z Carlos; Miriam Sannomiya; Wagner Vilegas
Journal:  BMC Complement Altern Med       Date:  2009-01-16       Impact factor: 3.659

6.  UHPLC-(ESI)-HRMS and NMR-Based Metabolomics Approach to Access the Seasonality of Byrsonima intermedia and Serjania marginata From Brazilian Cerrado Flora Diversity.

Authors:  Ana C Zanatta; Wagner Vilegas; RuAngelie Edrada-Ebel
Journal:  Front Chem       Date:  2021-07-06       Impact factor: 5.221

7.  Comparison of Brazilian Plants Used to Treat Gastritis on the Oxidative Burst of Helicobacter pylori-Stimulated Neutrophil.

Authors:  Cibele Bonacorsi; Luiz Marcos da Fonseca; Maria Stella Gonçalves Raddi; Rodrigo Rezende Kitagawa; Wagner Vilegas
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-18       Impact factor: 2.629

8.  Mutagenicity and antimutagenicity of six Brazilian Byrsonima species assessed by the Ames test.

Authors:  Lívia Greghi Espanha; Flávia Aparecida Resende; José de Sousa Lima Neto; Paula Karina Boldrin; Catarine Haidê Nogueira; Mariana Santoro de Camargo; Rone Aparecido De Grandis; Lourdes Campaner dos Santos; Wagner Vilegas; Eliana Aparecida Varanda
Journal:  BMC Complement Altern Med       Date:  2014-06-05       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.